홈0775 • HKG
add
CK Life Sciences Intl (Holdings) Inc
전일 종가
$0.50
일일 변동폭
$0.50 - $0.52
52주 변동폭
$0.30 - $0.61
시가총액
49.48억 HKD
평균 거래량
193.60만
주가수익률
-
배당수익률
-
기본 거래소
HKG
시장 뉴스
재무
손익계산서
수익
순이익
| (HKD) | 2024년 6월info | 전년대비 변동 |
|---|---|---|
수익 | 13.18억 | 2.20% |
운영비 | 3.24억 | -4.23% |
순이익 | 50.05만 | -97.29% |
순이익률 | 0.04 | -97.20% |
주당 수익 | — | — |
EBITDA | 1.17억 | 36.03% |
유효 세율 | 79.96% | — |
대차대조표
총자산
총부채
| (HKD) | 2024년 6월info | 전년대비 변동 |
|---|---|---|
현금 및 단기 투자 | 5.62억 | 11.10% |
총자산 | 108.89억 | -1.45% |
총부채 | 68.75억 | -0.11% |
총자기자본 | 40.14억 | — |
발행 주식 | 96.11억 | — |
주가순자산비율 | 1.18 | — |
총자산이익률 | 1.75% | — |
자본이익률 | 1.91% | — |
현금 흐름
순현금흐름
| (HKD) | 2024년 6월info | 전년대비 변동 |
|---|---|---|
순이익 | 50.05만 | -97.29% |
영업 현금 흐름 | 7270.15만 | 80.63% |
투자 현금 흐름 | -4788.15만 | -484.81% |
자금 조달 현금 흐름 | -7772.35만 | 41.39% |
순현금흐름 | -5756.00만 | 42.02% |
잉여 현금 흐름 | 3556.46만 | 91.21% |
정보
CK Life Sciences International Inc., or CK Life Sciences, is a subsidiary of CK Hutchison Holdings. It is engaged in research and development, commercialization, marketing and sale of biotechnology products. The chairman is Mr. Victor Li, the elder son of Mr. Li Ka-shing, the chairman of Cheung Kong Holdings.
It was established in 2000 and listed on the Hong Kong Stock Exchange via Growth Enterprise Market in 2002. It was transferred to Main Board of the Hong Kong Stock Exchange in 2008.
CK Life Sciences has operations in Australia, and in 2012 acquired an Australian salt company as part of its expansion into the agricultural sector.
The company divested its Canadian subsidiary WEX Pharmaceuticals to Virios Therapeutics for $100 million in October 2024. Wikipedia
CEO
설립
2000
직원 수
1,968
